SB-480848

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Atherosclerosis

Phase 2

SB-480848 In Subjects With Coronary Heart Disease

CompletedNCT00269048

GlaxoSmithKlineAtherosclerosis

Start: 2005-11-30End: 2006-09-30Updated: 2016-08-08

Integrated Biomarker And Imaging Study - 2

CompletedNCT00268996

GlaxoSmithKlineAtherosclerosis

Start: 2005-11-10End: 2007-08-28Updated: 2018-03-20